Unfortunately, a several hundred thousand euro grant that MAPS colleague and Spanish Researcher Jose Carlos Bouso, Ph.D. Candidate applied for to conduct an MDMA/PTSD study in Spain was rejected. MAPS will now pursue other avenues to conduct additional MDMA/PTSD research within the European Union. One of the ideas that we plan to implement will be to have future studies use an open label dosing regimen for the first two subjects. This means that the first two subjects in a study will receive MDMA, rather than MDMA or placebo. MAPS will use this as a chance to monitor the research teams adherence to the protocol guidelines.
